ANESC Research

El Paso, Texas 79912

9 studies enrolling now · 12 studies all time

What they study most

Acute Treatment of Migraine, Agitation, Alzheimer Disease, Focal Epilepsy, Focal Onset Seizures, Focal Seizures, Generalized Epilepsy, Generalized Myasthenia Gravis, Multiple Sclerosis, Pediatric Migraine, Primary Generalized Tonic-Clonic Seizures, Tonic-Clonic Seizures

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures — Recruiting now
• Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine — Recruiting now
• Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
• Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) — Recruiting now
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
• A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years — Recruiting now
• Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease — Recruiting now
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Running, not enrolling
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
• Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures — Stopped early